본문 바로가기
KERD
논문KCI 등재

섬유주세포에서 항혈관내피성장인자가 기질금속단백분해효소의 활성에 미치는 영향

Effect of Anti-vascular Endothelial Growth Factor on the Matrix Metalloproteinase Activity in Trabecular Meshwork Cells

김재우|신정욱|박현진
대한안과학회 (The Korean Ophthalmological Society)|2021.07|대한안과학회지 (Journal of The Korean Ophthalmological Society)|제62권 제7호|pp. 976-982

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

Nitric oxideMatrix metalloproteinaseBevacizumabTrabecular meshworkAnti-vascular endothelial growth factor
주제분류안과학

초록

목적: 섬유주세포에서 항혈관내피성장인자(anti-vascular endothelial growth factor, anti-VEGF)가 기질금속단백분해효소(matrix metalloproteinase, MMP)의 활성에 미치는 영향을 알아보고자 하였다. 대상과 방법: 인체의 섬유주세포를 배양한 다음 0.25, 0.50 mg/mL anti-VEGF bevacizumab (BV)을 24시간 노출시킨 다음, carboxyfluorescein을 이용하여 섬유주단층세포층의 투과도를 측정하였고 trans-epithelial endothelial electrical resistance (TEER)를 측정하였다. Western blot으로 MMP-1/-2 단백의 활성을 측정하였으며 Griess assay를 이용하여 일산화질소(nitric oxide, NO)의 생성 정도를 측정하였다. 결과: 0.50 mg/mL BV은 carboxyfluorescein의 섬유주단층세포층의 투과도를 유의하게 감소시켰으며(p=0.017) TEER에는 유의한 영향을 미치지 않았다(p=0.308). 0.50 mg/mL BV은 MMP-1/-2 단백의 활성을 각각 유의하게 감소시켰으며(p=0.014, p=0.016), 0.50 mg/mL BV은 NO의 생성을 유의하게 감소시켰다(p=0.023). 결론: Anti-VEGF는 섬유주단층세포층의 투과도를 감소시키며, 이와 동반하여 MMP-1/-2 단백의 활성과 NO의 생성을 감소시키는 작용을 나타낸다.

Abstract

Purpose: To investigate the effects of anti-vascular endothelial growth factor (anti-VEGF) on the activity of matrix metalloproteinase (MMP) in human trabecular meshwork cells (HTMC). Methods: Primary HTMC cultures were exposed to 0, 0.25, and 0.50 mg/mL anti-VEGF bevacizumab (BV) for 24 hours. The permeability through the trabecular meshwork cell monolayer was assessed using carboxyfluorescein and trans-epithelial endothelial electrical resistance (TEER). The levels of MMP-1/-2 were measured by Western blotting and the production of nitric oxide (NO) was assessed with the Griess assay. Results: Bevacizumab at 0.50 mg/mL decreased the permeability of carboxyfluorescein significantly (p = 0.017) and did not affect TEER (p = 0.308). Administration of 0.50 mg/mL BV decreased MMP-1 and MMP-2 activities (p = 0.014, p = 0.016, respectively) and inhibited NO production significantly (p = 0.023). Conclusions: Anti-VEGF decreased the permeability through the HTMC monolayer, which was accompanied by decreased MMP-1/-2 activity and limited NO production.

참고문헌 (46)

  1. Ferrara N, "The biology of vascular endothelial growth factor", Endocr Rev, 18, pp.4~25 (1997)
  2. Bakri SJ, "Persisent ocular hypertension following intravitreal ranibizumab", Graefes Arch Clin Exp Ophthalmol, 246, pp.955~958 (2008)
  3. Kahook MY, "Sustained elevation in intraocular pressure associated with intravitreal bevacizumab injections", Ophthalmic Surg Lasers Imaging, 40, pp.293~295 (2009)
  4. Good TJ, "Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents", Br J Ophthalmol, 95, pp.1111~1114 (2011)
  5. Mayhan WG, "VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase", cGMP-dependent pathway, 1999, pp.276, C1148~C1153
  6. Breslin JW, "VEGF increases endothelial permeability by separate signaling pathways involving ERK-1", 2and nitric oxide, 2003, pp.284, H92~H100
  7. Bouloumié A, "Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells", Cardiovasc Res, 41, pp.773~780 (1999)
  8. Dulak J, "Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells", Arterioscler Thromb Vasc Biol, 20, pp.659~666 (2000)
  9. Tilton RG, "Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF", Invest Ophthalmol Vis Sci, 40, pp.689~696 (1999)
  10. Lakshminarayanan S, "Effect of VEGF on retinal microvascular endothelial hydraulic conductivity : the role of NO", Invest Ophthalmol Vis Sci, 41, pp.4256~4261 (2000)
  11. Alvarado J, "Trabecular meshwork cellularity in primary open-angle glaucoma and nonglaucomatous normals", Ophthalmology, 91, pp.564~579 (1984)
  12. Rohen JW, "Ultrastructure of the trabecular meshwork in untreated cases of primary open-angle glaucoma(POAG)", Exp Eye Res, 56, pp.683~692 (1993)
  13. Keller KE, "Extracellular matrix turnover and outflow resistance", Exp Eye Res, 88, pp.676~682 (2009)
  14. Vranka JA, "Extracellular matrix in the trabecular meshwork : intraocular pressure regulation and dysregulation in glaucoma", Exp Eye Res, 133, pp.112~125 (2015)
  15. Unemori EN, "Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells", J Cell Physiol, 153, pp.557~562 (1992)
  16. Lamoreaux WJ, "Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro", Microvasc Res, 55, pp.29~42 (1998)
  17. Wang H, "Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells : role of flt-1", Circ Res, 83, pp.832~840 (1998)
  18. Stamer WD, "The many faces of the trabecular meshwork cell", Exp Eye Res, 158, pp.112~123 (2017)
  19. Grimes PA, "Carboxyfluorescein. A probe of the blood-ocular barriers with lower membrane permeability than fluorescein", Arch Ophthalmol, 100, pp.635~639 (1982)
  20. Araie M, "Carboxyfluorescein. A dye for evaluating the corneal endothelial barrier function in vivo", Exp Eye Res, 42, pp.141~150 (1986)
  21. Lei Y, "Oxidative stress impact on barrier function of porcine angular aqueous plexus cell monolayers", Invest Ophthalmol Vis Sci, 54, pp.4827~4835 (2013)
  22. Srinivasan B, "TEER measurement techniques for in vitro barrier model systems", J Lab Autom, 20, pp.107~126 (2015)
  23. Wilhelm I, "In vitro models of the blood-brain barrier", Acta Neurobiol Exp(Wars), 71, pp.113~128 (2011)
  24. nitrate in biological fluids, "Anal Biochem", 1982, 131~138
  25. Kahook MY, "In vitro effects of antivascular endothelial growth factors on cultured human trabecular meshwork cells", J Glaucoma, 19, pp.437~441 (2010)
  26. Spitzer MS, "Comparative antiproliferative and cytotoxic profile of bevacizumab(Avastin), pegaptanib(Macugen)and ranibizumab(Lucentis)on different ocular cells", Graefes Arch Clin Exp Ophthalmol, 245, pp.1837~1842 (2007)
  27. 김신후, "베바시주맙이 섬유주세포의 생존과 일산화질소의 생성에 미치는 영향", 대한안과학회지, 50(9), pp.1404~1408 (2009), 대한안과학회
  28. Kernt M, "Bevacizumab is not toxic to human anterior-and posterior-segment cultured cells", Ophthalmologe, 104, pp.965~971 (2007)
  29. Bradley JM, "Effect of matrix metalloproteinases activity on outflow in perfused human organ culture", Invest Ophthalmol Vis Sci, 39, pp.2649~2658 (1998)
  30. Pang IH, "Expression of matrix metalloproteinases and their inhibitors in human trabecular meshwork cells", Invest Ophthalmol Vis Sci, 44, pp.3485~3493 (2003)
  31. Hood JD, "VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells", Am J Physiol, 274, pp.H1054~H1058 (1998)
  32. Wiederholt M, "Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide", Invest Ophthalmol Vis Sci, 35, pp.2515~2520 (1994)
  33. Behar-Cohen FF, "Decreased intraocular pressure induced by nitric oxide donors is correlated to nitrite production in the rabbit eye", Invest Ophthalmol Vis Sci, 37, pp.1711~1715 (1996)
  34. Nathanson JA, "Alterations of ocular nitric oxide synthase in human glaucoma", Invest Ophthalmol Vis Sci, 36, pp.1774~1784 (1995)
  35. Löffek S, "Series"matrix metalloproteinases in lung health and disease" : biological role of matrix metalloproteinases : a critical balance", Eur Respir J, 38, pp.191~208 (2011)
  36. Yoshida M, "Nitric oxide increases matrix metalloproteinase-1 production in human uterine cervical fibroblast cells", Mol Hum Reprod, 7, pp.979~985 (2001)
  37. Chen HH, "Nitric oxide inhibits matrix metalloproteinase-2expression via the induction of activating transcription factor 3 in endothelial cells", Mol Pharmacol, 65, pp.1130~1140 (2004)
  38. Gurjar MV, "eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity", Arterioscler Thromb Vasc Biol, 19, pp.2871~2877 (1999)
  39. Alexander JP, "Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork", Invest Ophthalmol Vis Sci, 32, pp.172~180 (1991)
  40. Komarova Y, "Regulation of endothelial permeability via paracellular and transcellular transport pathways", Annu Rev Physiol, 72, pp.463~493 (2010)
  41. Ethier CR, "The inner wall of Schlemm's canal", Exp Eye Res, 74, pp.161~172 (2002)
  42. Tripathi RC, "Mechanism of the aqueous outflow across the trabecular wall of Schlemm's canal", Exp Eye Res, 11, pp.116~121 (1971)
  43. Tarkkanen A, "Enzyme histochemistry of the angle of the anterior chamber of the human eye", Acta Ophthalmol(Copenh), 45, pp.93~99 (1967)
  44. Salama NN, "Tight junction modulation and its relationship to drug delivery", Adv Drug Deliv Rev, 58, pp.15~28 (2006)
  45. Feng Y, "VEGF-induced permeability increase is mediated by caveolae", Invest Ophthalmol Vis Sci, 40, pp.157~167 (1999)
  46. Zhou Y, "Sustained elevation of intraocular pressure associated with intravitreal administration of anti-vascular endothelial growth factor : a systematic review and meta-analysis", Sci Rep, 6, pp.39301~ (2016)

관련 논문AI추천

섬유주세포에서 베바시주맙과 라니비주맙이 일산화질소합성효소의 발현에 미치는 영향김세은, 김재우대한안과학회 · 대한안과학회지2014 · 제55권 제8호Effect of Nitric Oxide on the Expression of Matrix Metalloproteinase and Its Association with Migration of Cultured Trabecular Meshwork Cells김재우대한안과학회 · Korean Journal of Ophthalmology2016 · 제30권 제1호일산화질소가 섬유주단층세포층의 투과성에 미치는 영향김재우, 김현연대한안과학회 · 대한안과학회지2015 · 제56권 제5호섬유주세포에서 호모시스테인이 기질금속단백분해효소-9의 발현과 세포고사에 미치는 영향김재우, 김정엽대한안과학회 · 대한안과학회지2023 · 제64권 제3호Effect of Prostaglandin E2 Agonist Omidenepag on the Expression of Matrix Metalloproteinase in Trabecular Meshwork Cells김재우, Jeong Yeub Kim대한안과학회 · Korean Journal of Ophthalmology2022 · 제36권 제2호섬유주세포에서 아데노신 A1 길항제에 의한 기질단백분해효소 2의 발현 조절김근해, 김재우, 백민주대한안과학회 · 대한안과학회지2018 · 제59권 제10호

이 간행물의 다른 논문 (19건)

스마트폰 카메라를 이용한 눈꺼풀처짐 환자의 눈꺼풀 깜박임 특성 분석주진호, 주태성, 박인기, 신재호pp. 873-880코-눈물주머니 점막피판을 이용한 코경유눈물주머니코안연결술의 결과김상덕, 정일원pp. 881-8870.03% Tacrolimus 연고의 소아 플릭텐각막염 치료 효과이종수, 조연지, 김재현pp. 888-894쇼그렌증후군 건성안 환자에서 0.1% 싸이클로스포린 A 점안액의 순응도 조사박도희, 윤희수, 윤현정, 윤경철, 진형남pp. 895-903비접촉안압계와 초음파 각막두께측정계를 이용하여 측정한 중심각막두께의 비교 분석박혜연, 신혜영pp. 904-909
원문 보기